Cite
APA Citation
Tazare, J., Wyss, R., Franklin, J. M., Smeeth, L., Evans, S. J. W., Wang, S. V., Schneeweiss, S., Douglas, I. J., Gagne, J. J., & Williamson, E. J. (2022). transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting. Pharmacoepidemiology and drug safety, 31(4), 411–423. http://access.bl.uk/ark:/81055/vdc_100152628499.0x00002c